ScholarGate
Ассистент

Сравнение методов

Просматривайте выбранные методы рядом; строки с различиями подсвечены.

Исследование Фазы IV с поправкой на риск×Когортное исследование×
ОбластьЭпидемиологияЭпидемиология
СемействоProcess / pipelineProcess / pipeline
Год появления1990s–2000s (formalized with ICH E2E and EMA PASS guidelines)Mid-20th century (formal epidemiological design codified ~1950s)
Автор методаRegulatory and pharmacoepidemiology community (ICH, EMA, FDA frameworks)Doll & Hill (British Doctors Study, 1951); Snow (cholera, 1854)
ТипObservational / quasi-experimental clinical study designObservational longitudinal study design
Основополагающий источникStrom, B. L. (Ed.). (2005). Pharmacoepidemiology (4th ed.). John Wiley & Sons. ISBN: 978-0470863107Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755641
Другие названияrisk-adjusted post-marketing surveillance study, adjusted Phase IV trial, risk-stratified post-authorization study, PASS with risk adjustmentlongitudinal study, follow-up study, panel study, incidence study
Связанные36
СводкаA risk-adjusted Phase IV study is an observational or semi-experimental post-marketing study conducted after a drug or device has received regulatory approval. It uses statistical risk-adjustment techniques — such as propensity score matching, inverse probability weighting, or multivariable regression — to control for confounding by indication and baseline patient differences, thereby producing more credible safety, effectiveness, and utilization estimates than unadjusted real-world analyses.A cohort study assembles a group of individuals who share a common starting point — typically freedom from the outcome of interest — and follows them over time to observe who develops the outcome. By comparing incidence rates between exposed and unexposed subgroups, researchers can estimate relative risk and absolute risk differences. Cohort studies are the gold-standard observational design for measuring disease incidence and establishing temporal relationships between exposure and outcome.
ScholarGateНабор данных
  1. v1
  2. 2 Источники
  3. PUBLISHED
  1. v1
  2. 2 Источники
  3. PUBLISHED

Перейти к поиску Скачать слайды

ScholarGateСравнение методов: Risk-adjusted Phase IV study · Cohort Study. Получено 2026-06-18 из https://scholargate.app/ru/compare